On March 9, we announced the Walk to End Colon Cancer, a fundraising event series that empowers a nation of allies to walk together and raise money to screen, care, and cure colorectal cancer. But by March 13, the Alliance’s offices were closed due to COVID-19 and the reality of the coming months came into focus.
Also in March, we were set to hold our last Undy RunWalk in St. Louis and the annual DC ScopeItOut 5K here. To ensure everyone’s safety, we combined the events virtually under the name ScopeItIn. The live broadcast was a fun, new way to engage our community and raise funds to end colorectal cancer.
In the months that followed, we tried new online ideas for our Walks in Chicago and Buffalo. We struggled to realize the power of in-person events in an online format, but gracious allies in those cities stepped up to do what they could and inspire giving.
Our fundraising events are critical components in our mission to end this disease in our lifetime, and we are dedicated to ensuring COVID-19 does not diminish our important work. We were hopeful that we could hold in-person events, but we know now that this is more promising for 2021.
As such, we’ve taken a new route for our Walk to End Colon Cancer that combines fundraising and walking in our own neighborhoods with a drive-through victory lap that will bring our community together in a safe and physically distanced way.
I encourage you to take part in these events, no matter where you live. Together, we will overcome our current adversity and become stronger than we’ve ever been. Sign up here:
In the face of a global pandemic, I’ve seen our community’s incredible adaptability and dedication to the cause. In many ways, the pandemic has shown that our community, our nation of allies, is stronger than we ever imagined. In the months ahead, there will be additional important calls to action — I know you will take part. Tomorrow can’t wait.
Thank you for being with us,
CEO, Colorectal Cancer Alliance
*Cleveland will not have a victory lap.
Don't miss another update.
Subscribe to our newsletter!